Research and analysis
Annex 2: Tables 1
Updated 28 June 2021
Download CSV 808 Bytes
| Study | Includes erythromycin, azithromycin or clarithromycin | Includes outcome of interest (MCM, CVM or miscarriage) | Comparator | Included or excluded | Reason for exclusion |
|---|---|---|---|---|---|
| Damkier P, Brønniche LM, Korch‐Frandsen JF, Broe A. In utero exposure to antibiotics and risk of congenital malformations: a population‐based study. American journal of obstetrics and gynecology. 2019 Dec 1;221(6):648‐e1 | yes (erythromycin, azithromycin) | MCM, CVM | women exposed to penicillin | included | N/A |
| Fan H, Gilbert R, O’Callaghan F, Li L. Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study. bmj. 2020 Feb 19;368. | yes (erythromycin, clarithromycin, azithromycin) | MCM, CVM | women exposed to penicillin | included | N/A |